RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Revenue (Most Recent Fiscal Year) | $1.83B |
Net Income (Most Recent Fiscal Year) | $2.79M |
PE Ratio (Current Year Earnings Estimate) | 250.86 |
PE Ratio (Trailing 12 Months) | 262.81 |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 2.22 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.64 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 15.85 |
Pre-Tax Margin (Trailing 12 Months) | 0.44% |
Net Margin (Trailing 12 Months) | -1.73% |
Return on Equity (Trailing 12 Months) | 1.41% |
Return on Assets (Trailing 12 Months) | 0.48% |
Current Ratio (Most Recent Fiscal Quarter) | 2.01 |
Quick Ratio (Most Recent Fiscal Quarter) | 2.01 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.87 |
Inventory Turnover (Trailing 12 Months) | -- |
Book Value per Share (Most Recent Fiscal Quarter) | $15.15 |
Earnings per Share (Most Recent Fiscal Quarter) | $-0.35 |
Earnings per Share (Most Recent Fiscal Year) | $0.63 |
Diluted Earnings per Share (Trailing 12 Months) | $-0.43 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Diagnostics & Research |
Common Shares Outstanding | 75.03M |
Free Float | 71.19M |
Market Capitalization | $4.14B |
Average Volume (Last 20 Days) | 0.74M |
Beta (Past 60 Months) | 1.46 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 5.12% |
Percentage Held By Institutions (Latest 13F Reports) | 77.90% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |